C. Doucet

发表

Gene therapy for rheumatoid arthritis

C. Jorgensen, A. Douar, M. Mezzina, 2002, The journal of gene medicine.

Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma.

G. Canonica, C. Jasmin, D. Brouty‐boye, 1998, The Journal of clinical investigation.

Novel Anti-inflammatory Effects of the Inhaled Corticosteroid Fluticasone Propionate During Lung Myofibroblastic Differentiation1

G. Canonica, S. Oddera, R. Testi, 2001, The Journal of Immunology.

This information is current as Differentiation Propionate During Lung Myofibroblastic Inhaled Corticosteroid Fluticasone Novel Anti-inflammatory Effects of the

G. Canonica, S. Oddera, R. Testi, 2001 .

New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy.

C. Huet, H. Carsin, I. Clairand, 2007, Regenerative medicine.

Restoration of Anal Sphincter Function after Myoblast Cell Therapy in Incontinent Rats

G. Gourcerol, S. L. Le Corre, L. Drouot, 2015, Cell transplantation.

Chemokines and CD40 expression in human fibroblasts

C. Jasmin, D. Brouty‐boye, B. Azzarone, 2000, European journal of immunology.

IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts.

G. Canonica, C. Jasmin, D. Brouty‐boye, 1998, International Immunology.

IL-15 is produced by a subset of human melanomas, and is involved in the regulation of markers of melanoma progression through juxtacrine loops

J. Ritz, S. Ferrini, C. Jasmin, 1998, Oncogene.

Human lung myofibroblasts as effectors of the inflammatory process: the common receptor γ chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF‐α

G. Canonica, B. Azzarone, J. Giron-Michel, 2002 .

Phenotypic diversity in human fibroblasts from myelometaplasic and non‐myelometaplasic hematopoietic tissues

M. Le Bousse-Kerdilès, T. Lampidis, D. Brouty‐boye, 1998 .

INTERLEUKIN (IL)-4 AND IL-13 ACT ON HUMAN LUNG FIBRO-BLAST

G. Canonica, C. Jasmin, C. Doucet, 1998 .

Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.

G. Canonica, B. Azzarone, J. Giron-Michel, 2002, European journal of immunology.

A new therapeutic approach for radiation burns combining surgery and mesenchymal stem cell administrations: About four cases

P. Gourmelon, E. Bey, C. Doucet, 2010 .

Chromosomal Instability but Lack of Transformation in Human Myoblast Preparations

T. Frebourg, P. Chambon, S. L. Le Corre, 2014, Cell transplantation.

Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications

X. Holy, Xavier Holy, Christelle Doucet, 2005, Journal of cellular physiology.

Mesenchymal stem cell abnormalities in patients with multiple myeloma

X. Holy, N. Gorin, L. Garderet, 2007, Leukemia & lymphoma.

A new platelet cryoprecipitate glue promoting bone formation after ectopic mesenchymal stromal cell-loaded biomaterial implantation in nude mice

Corinne Laplace-Builhé, P. Blancard, X. Holy, 2013, Stem Cell Research & Therapy.

Identification of an HLA-A*0201-restricted epitopic peptide from human dystrophin: application in duchenne muscular dystrophy gene therapy.

F. Ginhoux, J. Davoust, F. Lemonnier, 2003, Molecular therapy : the journal of the American Society of Gene Therapy.

Intrasphincteric injections of autologous muscular cells in women with refractory stress urinary incontinence: a prospective study

S. Medina, P. Sèbe, C. Pinset, 2011, International Urogynecology Journal.

Phenotypic diversity in human fibroblasts from myelometaplasic and non-myelometaplasic hematopoietic tissues.

M. Le Bousse-Kerdilès, T. Lampidis, D. Brouty‐boye, 1998, International journal of cancer.

Unusual interleukin-4 and -13 signaling in human normal and tumor lung fibroblasts

C. Jasmin, B. Azzarone, C. Doucet, 2000, Oncogene.

Role of interleukin (IL)-2 and IL‐15 in the tumour progression of a melanoma cell line MELP, derived from an IL‐2 progressor patient

S. Ferrini, C. Jasmin, F. Indiveri, 1997, Melanoma research.

[Radiation burn "innovating therapeutic approach"].

P. Gourmelon, E. Bey, J. Lataillade, 2010, Annales de chirurgie plastique et esthetique.

Bioengineering a Human Plasma‐Based Epidermal Substitute With Efficient Grafting Capacity and High Content in Clonogenic Cells

N. Fortunel, Michèle T. Martin, M. Trouillas, 2015, Stem cells translational medicine.

[Laparoscopy coupled with classical abdominoplasty in 10 cases of large rectus diastasis].

J. Faure, G. Dagregorio, J. Giot, 2012, Annales de chirurgie plastique et esthetique.

Proteomic study of Galectin-1 expression in human mesenchymal stem cells.

M. Caron, R. Joubert‐Caron, P. Bourin, 2005, Stem cells and development.

[Prospective evaluation of intrasphincteric injections of autologous muscular cells in patients with stress urinary incontinence following radical prostatectomy].

O. Cussenot, P. Sèbe, S. Gil Diez de Medina, 2011, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

IL2 triggers a tumor progression process in a melanoma cell line MELP derived from a patient whose metastasis increased in size during IL2/INFalpha biotherapy.

C. Jasmin, A. Poggi, F. Puppo, 1996, Oncogene.